Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	inf	0.00	59.15
Graham Fair Price	inf	0.00	0.42
PEG	0.00	0.00	0.00
Price/Book	inf	0.00	2.22
Price/Cash Flow	inf	0.00	-11.57
Prices/Earnings	inf	0.00	44.13
Price/Sales	inf	0.00	11.51
Price/FCF	inf	0.00	-11.57
Naive Interpretation	member

01 - Valuation · Not Interpreted

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	inf	0.00	0.39
Operating Margin	inf	0.00	0.19
ROA	n.A.	n.A.	< 0.005
ROE	0.01	n.A.	n.A.
ROIC	< 0.005	n.A.	n.A.
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	0.00	0.00
EPS QOQ	0.00	0.00	0.00
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	0.00	0.00	0.00
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.67	0.72	6.49
Quick Ratio	0.10	0.27	155.19
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.79	0.00	inf
Cash	0.12	0.00	inf
Capex	-0.14	0.00	inf
Free Cash Flow	-0.15	0.00	inf
Revenue	0.15	0.00	inf
Naive Interpretation	member

05 - Per Share Metrics · Not Interpreted

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.21	0.35	65.53
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	27.34	0.00	inf
Naive Interpretation	Member

06 - Financial Health · Bad

Rating